Method of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probe
US6190875A · kind A · utility
38Cited by
10References
61Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 10, 1998 |
| Grant date | Feb 20, 2001 |
| Priority date | — |
| Expiry date | Jul 10, 2018 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2500/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Qualitative and quantitative methods of testing an agent for its potential at inhibiting glycosidase catalytic activity, the methods including the steps of interacting a glycosidase enzyme with a glycosidase substrate in a presence of the agent and qualitatively or quantitatively evaluating an effect of the agent on the catalytic activity of the glycosidase enzyme toward the glycosidase substrate. Preferably the glycosidase enzyme is a heparanase enzyme and the glycosidase substrate is, respectively, a heparanase substrate.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.